SS Innovations International (SSII) Total Non-Current Liabilities (2020 - 2026)
SS Innovations International (SSII) reported Total Non-Current Liabilities of $35.8 million for Q1 2026, up 353.05% on a YoY basis from $7.9 million in Q1 2025, and little changed sequentially from $35.9 million in Q4 2025.
SS Innovations International (SSII) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
SS Innovations International (SSII) has 6 years of Total Non-Current Liabilities data on file, last reported at $35.8 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 353.05% year-over-year to $35.8 million; the trailing twelve-month figure through Mar 2026 stood at $35.8 million (up 353.05% YoY), and the FY2025 full-year result was $35.9 million, up 372.54% from the prior year.
- Total Non-Current Liabilities was little changed at $35.8 million in Q1 2026, from $35.9 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $35.9 million in Q4 2025 to a low of $1.9 million in Q4 2022.
- A 5-year average of $13.4 million and a median of $6.8 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Peak annual rise in Total Non-Current Liabilities reached 372.54% in 2025, while the deepest fall reached 45.86% in 2025.
- Tracing SSII's Total Non-Current Liabilities over 5 years: stood at $1.9 million in 2022, then jumped by 75.62% to $3.3 million in 2023, then jumped by 128.56% to $7.6 million in 2024, then jumped by 372.54% to $35.9 million in 2025, then slipped by 0.24% to $35.8 million in 2026.
- Business Quant data shows SSII's Total Non-Current Liabilities at $35.8 million in Q1 2026, $35.9 million in Q4 2025, and $29.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 35.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.82 Mn |
| Dec 31, 2025 | 35.90 Mn |
| Sep 30, 2025 | 29.74 Mn |
| Jun 30, 2025 | 27.84 Mn |
| Mar 31, 2025 | 7.91 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Sep 30, 2024 | 6.83 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Dec 31, 2023 | 3.32 Mn |
| Sep 30, 2023 | 3.29 Mn |
| Jun 30, 2023 | 3.28 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2020 | 4,630.00 |
| Jun 30, 2020 | 4,630.00 |